CIM Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $869K | Buy |
3,048
+1,521
| +100% | +$434K | 0.17% | 115 |
|
2025
Q1 | $372K | Sell |
1,527
-1
| -0.1% | -$244 | 0.08% | 143 |
|
2024
Q4 | $502K | Buy |
1,528
+7
| +0.5% | +$2.3K | 0.15% | 115 |
|
2024
Q3 | $509K | Sell |
1,521
-28
| -2% | -$9.37K | 0.15% | 118 |
|
2024
Q2 | $423K | Sell |
1,549
-9
| -0.6% | -$2.46K | 0.13% | 139 |
|
2024
Q1 | $539K | Hold |
1,558
| – | – | 0.16% | 124 |
|
2023
Q4 | $503K | Sell |
1,558
-88
| -5% | -$28.4K | 0.16% | 128 |
|
2023
Q3 | $590K | Sell |
1,646
-38
| -2% | -$13.6K | 0.22% | 100 |
|
2023
Q2 | $638K | Buy |
1,684
+4
| +0.2% | +$1.52K | 0.22% | 98 |
|
2023
Q1 | $805K | Buy |
1,680
+1,115
| +197% | +$534K | 0.3% | 68 |
|
2022
Q4 | $238K | Sell |
565
-16
| -3% | -$6.73K | 0.09% | 199 |
|
2022
Q3 | $242K | Hold |
581
| – | – | 0.11% | 179 |
|
2022
Q2 | $288K | Sell |
581
-3
| -0.5% | -$1.49K | 0.12% | 167 |
|
2022
Q1 | $329K | Buy |
+584
| New | +$329K | 0.11% | 171 |
|